IFNA2 and neoplasm: We hypothesized that perilesional IFNα2b would induce tumor regression in treated horses with minimal side effects, that larger or more invasive lesions would be less likely to respond, and that homozygosity for the DDB missense variant and/or anti-IFNα2b serum antibodies would be associated with lack of treatment responses.